The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: -0.50 (-3.08%)
Spread: 0.50 (3.226%)
Open: 16.25
High: 16.25
Low: 15.70
Prev. Close: 16.25
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: UK stocks rise as Paris and Frankfurt head lower

Thu, 22nd Dec 2022 12:10

(Alliance News) - Stock prices in London were higher at midday on Thursday, ahead of some key US economic data, while equities elsewhere were less buoyant.

The FTSE 100 index was up 34.11 points, 0.5%, at 7,531.43. The FTSE 250 was up 62.80 points, 0.3%, at 18,926.45 , and the AIM All-Share was down just 0.2 of a point, at 830.22.

The Cboe UK 100 was up 0.4% at 752.75, the Cboe UK 250 was up 0.4% at 16,376.71, and the Cboe Small Companies was up 0.1% at 12,933.78.

"The markets seem to be heading into Christmas on a slightly more hopeful note amid signs the US consumer is proving more resilient than feared," said AJ Bell investment director Russ Mould.

This positivity did not extend to European equities, which had fallen into the red by early afternoon Thursday. The CAC 40 in Paris was marginally lower, while the DAX 40 in Frankfurt was down 0.2%.

Consumer confidence in the US economy improved in December, bouncing more than expected as inflation expectations eased and gasoline prices cooled, survey data showed on Wednesday.

The closely watched consumer confidence index rose more than analysts predicted to 108.3 points this month, markedly higher than the revised 101.4 figure in November, said think tank the Conference Board.

There are more US economic indicators to come on Thursday, with US weekly unemployment insurance claims, as well as a gross domestic product print, and personal consumption expenditures.

Annualised US GDP growth is expected to be confirmed at 2.9% in the third quarter.

The dollar was mixed ahead of the data, while stocks in New York were called lower.

Sterling was quoted at USD1.2062 early Thursday, lower than USD1.2093 at the London equities close on Wednesday. The euro traded at USD1.0629, higher than USD1.0612. Against the yen, the dollar was quoted at JPY132.18, firm versus JPY132.08.

The Dow Jones Industrial Average, the S&P 500, and the Nasdaq Composite all were called down 0.3%.

Earlier on Thursday, a new UK GDP print showed a sharper decline in the third quarter than previously forecast.

The UK economy is now estimated to have contracted by 0.3% between July to September. This was downwardly revised from a previous estimate of a 0.2% decline. It mainly reflects revisions to production and construction output estimates, ONS said.

The estimates were adjusted due to the additional bank holiday in September for the state funeral of Queen Elizabeth II, which saw businesses close or reduce their operations.

Meanwhile, annual real UK GDP was revised upwards to 7.6% growth in 2021 from a previous estimate of 7.5%. Despite this, downward revisions in 2022 meant that real GDP is now estimated to be 0.8% below its pre-pandemic size.

This compares with a previous estimate of being just 0.4% below. The estimate shows the UK is the only G7 country to continue to fall short of its pre-pandemic performance.

"There is clearly a caveat in that the UK did shutter shops and close offices and factories to allow people to take time off to pay their respects to the late Queen. But all in all, it's hard to find the silver lining in these gathering storm clouds," said AJ Bell's Danni Hewson.

Gold was quoted at USD1,814.65 an ounce at midday on Thursday, edging down from USD1,815.20 on Wednesday. Brent oil fetched USD83.69 a barrel, higher than USD81.68.

In London, FTSE 100 heavyweights BP and Shell were up 1.7% and 1.0% respectively, tracking the oil price higher.

Amid a more risk-on mood, defensive stocks such as United Utilities and British American Tobacco were succumbing to selling pressure, losing 2.1% and 1.2% respectively.

In the FTSE 250, DiscoverIE was up 1.0%, having returned some of its early morning gain.

The specialised electronic components firm has acquired Magnasphere, a US-based company that designs and manufactures magnetic sensors and switches for industrial electronic purposes. It will pay out USD22 million on a debt-free, cash-free basis before expenses, funded from existing debt facilities.

The acquisition will be immediately accretive to underlying earnings and underlying operating margin, discoverIE said.

"This acquisition of Magnasphere continues our strategy of building a differentiated, international, growth-focused electronics group with strong operating margin," said discoverIE Chief Executive Nick Jefferies.

On AIM, Tekmar surged up 50%.

The offshore energy markets services and technology provider won a new contract to supply cable protection systems to phase three of the UK's Dogger Bank C wind farm. The award comes from DEME Offshore.

The 3.6 gigawatt wind farm is located off the north east coast of England. Tekmar will design, manufacture and supply a further 172 CPS, having already supplied 380 CPS in the A and B project phases at Dogger Bank. It provided no financial details.

Destiny Pharma also added 10%.

The clinical-stage biotechnology company, said the completion of a partnering agreement for its NTCD-M3 phase 3 drug is expected in early 2023.

The company said it had entered exclusive negotiations with a US pharmaceutical company to secure a commercialisation partner for NTCD-M3 - its lead asset for the prevention of clostridioides difficile infection recurrence.

Thursday is the last full day of trading in London before Christmas, before an early finish at 1230 GMT on Friday.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.

More News
20 May 2022 16:00

UK shareholder meetings calendar - next 7 days

Monday 23 May 
Brewin Dolphin Holdings PLCGM re acquisition by RBC Wealth Management
Digital 9 Infrastructure PLCAGM
Empiric Student Property PLCAGM
TMT Investments PLCAGM
Tuesday 24 May 
4imprint Group PLCAGM
Afentra PLCAGM
Artisanal Spirits Co PLCAGM
Bidstack Group PLCAGM
Epwin Group PLCAGM
FDM Group Holdings PLCAGM
Forterra PLCAGM
Harworth Group PLCAGM
Henderson High Income Trust PLCAGM
Hill & Smith Holdings PLCAGM
Hilton Food Group PLCAGM
Horizonte Minerals PLCAGM
Judges Scientific PLCAGM
Pebble Group PLCAGM
Quarto Group IncAGM
Restaurant Group PLCAGM
Riverstone Energy LtdAGM
Shell PLCAGM
Thungela Resources LtdAGM
Vector Capital PLCAGM
WPP PLCAGM
Wednesday 25 May  
Access Intelligence PLCAGM
Amur Minerals CorpAGM
Aston Martin Lagonda Global Holdings PLCAGM
Bakkavor Group PLCAGM
Bango PLCAGM
Bodycote PLCAGM
Eleco PLCAGM
International Public Partnerships LtdAGM
Intertek Group PLCAGM
M&G PLCAGM
Manx Financial Group PLCAGM
Mortgage Advice Bureau Holdings PLCAGM
Property Franchise Group PLCGM re final 2021 dividend
Regional REIT LtdAGM
Sabre Insurance Group PLCAGM
Trustpilot Group PLCAGM
Tullow Oil PLCAGM
Zenova Group PLCAGM
Zotefoams PLCAGM
Thursday 26 May 
Aminex PLCAGM
Bank of Ireland Group PLCAGM
Belvoir Group PLCAGM
Central Asia Metals PLCAGM
Curtis Banks Group PLCAGM
Diaceutics PLCAGM
Duke Royalty LtdEGM re fundraise
East Star Resources PLCAGM
Energean PLCAGM
Henry Boot PLCAGM
Hochschild Mining PLCAGM
Legal & General Group PLCAGM
National World PLCAGM
Ocean Wilsons Holdings LtdAGM
OnTheMarket PLCGM re cancellation of capital
Prudential PLCAGM
S&U PLCAGM
Staffline Group PLCAGM
Strix Group PLCAGM
WAG Payment Solutions PLCAGM
Yu Group PLCAGM
Friday 27 May 
AG Barr PLCAGM
Big Technologies PLCAGM
Coca-Cola Europacific Partners PLCAGM
Destiny Pharma PLCAGM
Hostmore PLCAGM
Lancashire Holdings LtdAGM
Lekoil LtdEGM re appointment and remuneration of auditors
LSL Property Services PLCAGM
Malin Corp PLCAGM
Old Mutual LtdAGM
Oxford BioMedica PLCAGM
Renewables Infrastructure Group LtdAGM
Spectris PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
12 May 2022 19:45

TRADING UPDATES: Belluscura to raise GBP5 million; React buys

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
3 May 2022 21:55

TRADING UPDATES: Vela, Standard Life Investments up portfolio value

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
3 May 2022 12:16

Destiny Pharma appoints Yuri Martina as chief medical officer

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the appointment of Dr Yuri Martina as its chief medical officer on Tuesday.

Read more
12 Apr 2022 12:42

EARNINGS UPDATES: Parsley Box widens loss; M Winkworth profit doubles

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
5 Apr 2022 16:34

UK earnings, trading statements calendar - next 7 days

Wednesday 6 April  
Applied Graphene Materials PLCHalf Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Hilton Food Group PLCFull Year Results
Hyve Group PLCTrading Statement
Topps Tiles PLCTrading Statement
Wentworth Resources PLCFull Year Results
Thursday 7 April 
Alpha Financial Markets Consulting PLCTrading Statement
Attraqt Group PLCFull Year Results
Entain PLCQ1 Results
Robert Walters PLCQ1 Results
Tracsis PLCHalf Year Results
Friday 8 April 
CMC Markets PLCTrading Statement
Ferrexpo PLCTrading Statement
Monday 11 April 
Tortilla Mexican Grill PLCFull Year Results
Sirius Real Estate LtdTrading Statement
Tuesday 12 April 
ASOS PLCHalf Year Results
Cambridge Cognition Holdings PLCFull Year Results
Destiny Pharma PLCFull Year Results
easyJet PLCTrading Statement
Filta Group Holdings PLCFull Year Results
JD Sports Fashion PLCFull Year Results
Liontrust Asset ManagementTrading Statement
M Winkworth PLCFull Year Results
Moneysupermarket.com Group PLCTrading Statement
Nanoco Group PLCHalf Year Results
Pennon Group PLCTrading Statement
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
25 Mar 2022 14:26

IN BRIEF: Destiny Pharma raises GBP450,000 through open offer

Destiny Pharma PLC - a clinical-stage biotechnology company based in Brighton, England - Raises total gross proceeds of GBP450,000 through its open offer. Has conditionally raised total gross proceeds of GBP6.5 million through its placing, subscription, and open offer. Says it has applied for the admission of 12.9 million shares, consisting of 11.9 million placing shares, 140,000 subscription shares and 909,007 open offer shares.

Read more
8 Mar 2022 19:38

IN BRIEF: Destiny Pharma to raise GBP7.0 million for asset trials

Destiny Pharma PLC - clinical-stage biotechnology company based in Brighton, England - Intends to raise GBP7.0 million through a placing of 11.9 million shares at 50 pence each, subscription for 140,000 shares and an open offer for 2.0 million shares.

Read more
8 Mar 2022 13:55

Destiny Pharma to raise up to £7m in discounted fundraising

(Sharecast News) - Clinical stage biotechnology company Destiny Pharma said on Tuesday that it was looking to raise up to £7m in a conditional fundraising to continue progress towards Phase 3 in its two lead clinical assets.

Read more
8 Feb 2022 20:36

IN BRIEF: Destiny Pharma receives Europe watchdog XF-73 boost

IN BRIEF: Destiny Pharma receives Europe watchdog XF-73 boost

Read more
8 Feb 2022 15:07

Destiny upbeat on nasal gel feedback from EMA

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma said on Tuesday that it has received positive scientific advice from the European Medicines Agency (EMA), following its review of its proposed phase 3 clinical programme design.

Read more
1 Feb 2022 14:57

Destiny successfully completes preclinical study of dermal formulation

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the successful completion of a preclinical safety study with a novel 'XF-73' dermal formulation on Tuesday.

Read more
24 Jan 2022 13:44

Destiny Pharma reports success in US C. diff trial

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the successful outcome of its cooperative research and development agreement with the US Department of Veterans Affairs (VA) on Monday.

Read more
21 Jan 2022 14:36

IN BRIEF: Destiny Pharma notes study that shows need for XF platform

IN BRIEF: Destiny Pharma notes study that shows need for XF platform

Read more
17 Jan 2022 18:40

TRADING UPDATES: MP Evans declares special payout as production rises

TRADING UPDATES: MP Evans declares special payout as production rises

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.